These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 8137625
1. Contraceptive methods and risk of pelvic endometriosis. Parazzini F, Ferraroni M, Bocciolone L, Tozzi L, Rubessa S, La Vecchia C. Contraception; 1994 Jan; 49(1):47-55. PubMed ID: 8137625 [Abstract] [Full Text] [Related]
5. Intrauterine device use and risk of endometrial cancer. Parazzini F, La Vecchia C, Moroni S. Br J Cancer; 1994 Oct; 70(4):672-3. PubMed ID: 7917915 [Abstract] [Full Text] [Related]
6. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962 [Abstract] [Full Text] [Related]
7. Correlates of oral contraceptive use in Italian women, 1991-93. Parazzini F, Negri E, Ricci E, Franceschi S, La Vecchia C. Contraception; 1996 Aug; 54(2):101-6. PubMed ID: 8842587 [Abstract] [Full Text] [Related]
11. Current use of an intrauterine device and risk of tubal pregnancy. Rossing MA, Daling JR, Voigt LF, Stergachis AS, Weiss NS. Epidemiology; 1993 May; 4(3):252-8. PubMed ID: 8512989 [Abstract] [Full Text] [Related]
12. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Vessey MP, Lawless M, McPherson K, Yeates D. Lancet; 1983 Oct 22; 2(8356):930-4. PubMed ID: 6138502 [Abstract] [Full Text] [Related]
13. Oral contraceptive use and cervical intraepithelial neoplasia. Coker AL, McCann MF, Hulka BS, Walton LA. J Clin Epidemiol; 1992 Oct 22; 45(10):1111-8. PubMed ID: 1474407 [Abstract] [Full Text] [Related]
14. Risk factors for epithelial ovarian tumours of borderline malignancy. Parazzini F, Restelli C, La Vecchia C, Negri E, Chiari S, Maggi R, Mangioni C. Int J Epidemiol; 1991 Dec 22; 20(4):871-7. PubMed ID: 1800425 [Abstract] [Full Text] [Related]
15. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Rosenberg MJ, Waugh MS, Meehan TE. Contraception; 1995 May 22; 51(5):283-8. PubMed ID: 7628201 [Abstract] [Full Text] [Related]
16. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis. Vercellini P, De Giorgi O, Oldani S, Cortesi I, Panazza S, Crosignani PG. Am J Obstet Gynecol; 1996 Aug 22; 175(2):396-401. PubMed ID: 8765259 [Abstract] [Full Text] [Related]
17. Determinants of oral contraceptive use in northern Italy. La Vecchia C, Decarli A, Parazzini F, Gentile A, Negri E, Franceschi S. Contraception; 1986 Aug 22; 34(2):145-56. PubMed ID: 3780230 [Abstract] [Full Text] [Related]
18. Oral contraceptives and breast cancer: a cooperative Italian study. La Vecchia C, Negri E, Franceschi S, Talamini R, Amadori D, Filiberti R, Conti E, Montella M, Veronesi A, Parazzini F. Int J Cancer; 1995 Jan 17; 60(2):163-7. PubMed ID: 7829209 [Abstract] [Full Text] [Related]
19. [Disease and contraception. Recent aspects]. Rozenbaum H. Contracept Fertil Sex (Paris); 1985 Jan 17; 13(1 Suppl):431-6. PubMed ID: 12280211 [Abstract] [Full Text] [Related]
20. Oral contraceptives and breast cancer in northern Italy. Final report from a case-control study. Tavani A, Negri E, Franceschi S, Parazzini F, La Vecchia C. Br J Cancer; 1993 Sep 17; 68(3):568-71. PubMed ID: 8353047 [Abstract] [Full Text] [Related] Page: [Next] [New Search]